NCT05318222 Genetic Inclusion by Virtual Evaluation
| NCT ID | NCT05318222 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor College of Medicine |
| Condition | Birth Defects |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-06-01 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagene to provide remote evaluation and genomic sequencing for improving genetic health of less resourced children with rare disorders living along the Texas-Mexico border.
Eligibility Criteria
Inclusion Criteria: Pediatric patients with undiagnosed rare genetic diseases residing in the Rio Grande Valley and El Paso in Texas Exclusion Criteria: Children with known genetic diseases
Contact & Investigator
Seema Lalani
PRINCIPAL INVESTIGATOR
Baylor College of Medicine
Frequently Asked Questions
Who can join the NCT05318222 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 18 Years, studying Birth Defects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05318222 currently recruiting?
Yes, NCT05318222 is actively recruiting participants. Contact the research team at seemal@bcm.edu for enrollment information.
Where is the NCT05318222 trial being conducted?
This trial is being conducted at Edinburg, United States.
Who is sponsoring the NCT05318222 clinical trial?
NCT05318222 is sponsored by Baylor College of Medicine. The principal investigator is Seema Lalani at Baylor College of Medicine. The trial plans to enroll 200 participants.